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INTRODUCTION 
 Infection of cattle with Bovine herpesvirus 1 (BHV-1) can 
result in conjunctivitis, pneumonia, genital disorders, abor-
tions and “shipping fever,” an upper respiratory tract infection 
(Tikoo et al., 1995). BHV-1 infection of bovine cells leads to 
rapid cell death and an increase in apoptosis (Devireddy & 
Jones, 1999). Viral gene expression is regulated in three dis-
tinct temporal phases: immediate-early (IE), early (E) and 
late (L) (Jones, 2003). The bICP0 protein is encoded by IE 
transcription unit 1 (Wirth et al., 1992) and activates expres-
sion of all three classes of viral promoter (Everett, 2000). The 
bICP0 gene is expressed constitutively during productive in-
fection, as it has an IE and an E promoter that are activated by 
bICP0 (Figure 1a; Fraefel et al., 1994). bICP0 associates with 
histone deacetylase 1 (HDAC1) and, in quiescent cells, bICP0 
relieves HDAC1-mediated repression of transcription (Zhang 
& Jones, 2001). The ability of bICP0 to interact with HDAC1 
may stimulate viral gene expression. Construction of a mutant 
BHV-1 that does not express the bICP0 protein has demon-
strated that bICP0 plays an important role in productive infec-
tion of cultured bovine cells (Geiser et al., 2005). 
The ICP0 homologues encoded by BHV-1 and Human herpes-
virus 1 (herpes simplex virus type 1, HSV-1) contain a well-
conserved C3HC4 zinc RING fi nger near their respective N ter-
mini. Mutational analysis has demonstrated the importance of 
the C3HC4 zinc RING-fi nger
 domain of bICP0 and ICP0 (Ev-
erett, 1987, 1988; Everett et al., 1993; Inman et al., 2001b). 
ICP0 (Everett et al., 1997, 1999a, b; Maul & Everett, 1994; 
Maul et al., 1993) and bICP0 (Inman et al., 2001b; Parkinson 
& Everett, 2000) co-localize with and disrupt the proto-onco-
gene promyelocytic leukaemia protein-containing nuclear do-
mains (ND10 or PODs). ICP0 regulates steady-state levels of 
cellular and viral proteins, due to its interaction with the pro-
tein-degradation machinery (Everett et al., 1997, 1999a) and 
E3 ubiquitin ligase activity (Boutell et al., 2002; Van Sant et 
al., 2001). The E3 ubiquitin ligase activity of ICP0 disrupts 
the cell cycle and alters cellular gene expression (for example, 
p21, gadd45 and mdm-2) (Hobbs & DeLuca, 1999; Lomonte 
& Everett, 1999). 
During productive infection, HSV-1 DNA is associated with 
histones (Herrera & Triezenberg, 2004; Kent et al., 2004), sug-
gesting that effi cient viral gene expression requires an ‘open’ 
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Abstract: The immediate-early protein, bICP0, of Bovine herpesvirus 1 (BHV-1) transactivates viral promoters and stim-
ulates productive infection. bICP0 is expressed constitutively during productive infection, as its gene contains an imme-
diate-early and an early promoter. Like other ICP0 homologues encoded by members of the subfamily Alphaherpesviri-
nae, bICP0 contains a zinc RING fi nger located near its N terminus. Mutations that disrupt the bICP0 zinc RING fi nger 
impair its ability to activate transcription, stimulate productive infection, inhibit interferon-dependent transcription in certain 
cell types and regulate subnuclear localization. bICP0 also interacts with a cellular chromatin-remodelling enzyme, his-
tone deacetylase 1 (HDAC1), and can relieve HDAC1-mediated transcriptional repression, suggesting that bICP0 inhib-
its silencing of the viral genome. In this study, it was shown that bICP0 interacted with the histone acetyltransferase p300 
during productive infection and in transiently transfected cells. In addition, p300 enhanced BHV-1 productive infection and 
transactivated a late viral promoter (gC). In contrast, a CH3-domain deletion mutant of p300, which is a dominant-nega-
tive mutant, did not activate the gC promoter. bICP0 and p300 cooperated to activate the gC promoter, suggesting that 
there is a synergistic effect on promoter activation. As p300 can activate certain antiviral signalling pathways (for exam-
ple, interferon), it was hypothesized that interactions between p300 and bICP0 may dampen the antiviral response follow-
ing infection.
1843
1844  ZHANG ET AL. IN JOURNAL OF GENERAL VIROLOGY 87 (2006)
Figure 1. Schematic of the BHV-1 genome and bICP0 protein-coding sequences. (a) Schematic of BHV-1 genes in the 
repeats. The positions of IE transcripts (Fraefel et al., 1993; Wirth et al., 1989, 1991, 1992) and the LR transcript (De-
vireddy et al., 2003; Hossain et al., 1995; Kutish et al., 1990) are presented. IE/4.2 encodes bICP4 and IE/2.9 encodes 
bICP0. One IE promoter (denoted by a fi lled rectangle) activates expression of IE/4.2 and IE/2.9 and this IE transcrip-
tion unit is designated IEtu1. E/2.6 is the early transcript that encodes bICP0 and an early promoter (denoted by a striped 
box) activates expression of this transcript. Exon 2 (e2) of bICP0 contains all of the protein-coding sequences of bICP0. 
The origin of replication (ORI) separates IEtu1 from IEtu2. IEtu2 encodes the bICP22 protein. Solid lines in the transcript 
position map represent exons (e1, e2 and e3). (b) The bICP0 protein-coding sequences were cloned into a Flag-tagged 
CMV expression plasmid (pCMVbICP0) and this construct was designated bICP0 (Inman et al., 2001b). The positions of 
the zinc RING fi nger and the acidic domain have been described previously (Wirth et al., 1992). The SalI site in bICP0 
was used to construct the ΔC terminus construct. The simian virus 40 poly(A) addition site is located at the 3’ termi-
nus of the bICP0 insert. The amino acid sequences of theC3HC4 zinc RING fi ngers of BHV-1 bICP0 (aa 13–51) are pre-
sented. The mutations in bICP0 are shown (aa 13 was changed from C to G and aa 51 from C to A). The procedures for 
site-directed mutagenesis have been described previously (Inman et al., 2001b). (c) 293 cells (2x106) were transfected 
with CMV Flag-tagged expression plasmids expressing wt bICP0, the ΔbICP0 protein, the 13G/51A mutant protein or 
an empty expression vector (pcDNA3.1) (V) using 20 μg DNA. At 48 h post-transfection, cell lysate was prepared and a 
Western blot was performed using methods described previously (Inman et al., 2001b; Zhang & Jones, 2001). The Flag-
tagged bICP0 proteins were detected with a Flag-specifi c antibody (Stratagene).
chromatin structure. When BHV-1 DNA is transfected into 
permissive cells, plaque formation is ineffi cient unless bICP0 
or HSV-1 ICP0 is included in the transfection mix (Geiser & 
Jones, 2003; Inman et al., 2001b). When the adenovirus E1A 
gene is co-transfected with BHV-1 DNA, plaque formation is 
also increased (Geiser & Jones, 2003), suggesting that E1A 
and bICP0 share certain common functions. The ability of the 
E1A protein to bind the histone acetyltransferase p300 and in-
hibit its histone acetyltransferase (HAT) activity promotes ad-
enovirus productive infection (Chakravarti et al., 1999; Hama-
mori et al., 1999). 
p300/CBP [cAMP response element-binding protein (CREB)-
binding protein] is a ubiquitously expressed, global tran-
scriptional co-activator that interacts with numerous DNA-
binding transcription factors and nuclear-hormone receptors. 
p300 plays pivotal roles in many cellular processes, includ-
ing cell-cycle control, differentiation and apoptosis (Chan & 
La Thangue, 2001; Vo & Goodman, 2001). p300 possesses 
intrinsic HAT activity that, in general, stimulates transcrip-
tion (Grunstein, 1997; Tsukiyama & Wu, 1997) and promotes 
chromatin remodelling (Ogryzko et al., 1996). p300 can also 
acetylate various transcription factors (Sterner & Berger, 
2000). p300 shares several conserved functional domains: (i) 
the bromodomain frequently found in mammalian HATs; (ii) 
three cysteine/histidine-rich domains (CH1, CH2 and CH3); 
and (iii) a KIX domain that binds the kinase-inducible domain 
of CREB. The CH1, CH3 and KIX domains are important for 
protein–protein interactions (Eckner et al., 1994; Lundblad et 
al., 1995). Many viral proteins target p300 and these interac-
tions induce cell-growth control, stimulate DNA synthesis and 
block cellular differentiation (Avantaggiati et al., 1996; Eck-
ner et al., 1994; Lundblad et al., 1995; Nemethova & Winters-
berger, 1999; Patel et al., 1999; Van Orden et al., 1999; Wang 
et al., 2000). 
In this study, we have demonstrated that bICP0 associates 
with p300 in productively infected bovine cells or cells trans-
fected with bIPC0. Co-transfection of p300 with BHV-1 DNA 
enhanced plaque formation in bovine cells. In transient-trans-
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fection assays, p300 and bICP0 stimulated the BHV-1 gC pro-
moter. When p300 and bICP0 were co-transfected with the gC 
promoter, gC promoter activity was higher than in cells trans-
fected with just p300 or bICP0. 
METHODS 
Cells. Rabbit skin (RS) cells, Madin–Darby bovine kidney (MDBK) 
cells, bovine testicular cells (9.1.3) and human epithelial 293 cells 
were grown in Earle’s modifi ed Eagle’s medium supplemented with 5 
% fetal bovine serum. Fetal bovine lung (FBL) cells were maintained 
in Earle’s modifi ed Eagle’s medium supplemented with 10 % fetal bo-
vine serum. All medium contained penicillin (10 U ml–1) and strepto-
mycin (100 μg ml–1). 
Plasmids. pCMV-bICP0 contained the bICP0-coding sequences un-
der the control of the cytomegalovirus (CMV) promoter. Mutagenesis 
of the bICP0 zinc RING fi nger has been described previously (Inman 
et al., 2001b). The coding regions of the wild-type (wt) bICP0 and the 
zinc RING-fi nger mutant 13G/51A were inserted into the Flag-tagged 
expression vectors pCMV2C (bICP0) and pCMV4B (13G/51A) 
(Stratagene), respectively. A C-terminal deletion of bICP0 (ΔbICP0) 
was generated by deleting the SalI–XhoI fragment (aa 356–676) 
from the Flag-tagged bICP0 construct. pCMV300 contained wild-
type p300 cDNA. The dominant-negative mutation pCMV300ΔCH1 
was generated by deletion of the CH1 domain (aa 348–411, nt 2242–
2433). pCMV300ΔCH3 was generated by deletion of the CH3 do-
main (aa 1737–1836, nt 6405–6704). The p300 constructs were pur-
chased from Upstate. 
Transient expression for Western blot analysis. 293 cells 
(~2x106 in a 100 mm dish) were transfected with 20 μg of the desig-
nated bICP0 expression plasmid by using the calcium phosphate pre-
cipitation method. At 40 h post-transfection, cells were collected and 
lysed in 500 μl 1x SDS sample buffer [50 mM Tris/HCl (pH 6.8), 10 
% glycerol, 2 % SDS, 5 % β-mercaptoethanol]. Lysed cells were boiled 
for 5 min and the supernatant was used for SDS-PAGE. The wt and 
mutant forms of the bICP0 protein were detected by using an anti-Flag 
antibody (Stratagene). 
Co-immunoprecipitation assay. Each Flag-tagged bICP0 expres-
sion vector (10 μg) was transfected with 10 μg p300 expression vec-
tor into 293 cells (~2x106 in a 100 mm dish) by calcium phosphate 
precipitation. At 40 h post-transfection, cells were collected and sus-
pended in 250 μl lysis buffer [20 mM HEPES/KOH (pH 7.9), 400 mM 
KCl, 1.5 mM MgCl2,
 0.2 mM EDTA, 20 % glycerol, 0.5 mM dithioth-
reitol, complete proteinase inhibitors at one tablet per 10 ml]. Whole-
cell lysate was sonicated and centrifuged for 10 min at 4 °C in an Ep-
pendorf centrifuge (15 000 r.p.m.). The supernatant was diluted to a 
fi nal volume of 1 ml with the same lysis buffer, except for the addi-
tion of 20 mM KCl. Protein G magnetic beads (25 μl) were added. 
The mixture was incubated at 4 °C for 1 h and the beads were col-
lected by using a magnetic separation rack and then discarded. The su-
pernatant was incubated with 5 μg anti-Flag antibody at 4 °C over-
night. Protein G magnetic beads (25 μl) were added and incubated for 
1 h at 4 °C on a rotating device. The beads were collected and washed 
four times with wash buffer [10 mM Tris/HCl (pH 8.0), 50 mM NaCl, 
1 mM EDTA, 0.5 % NP-40]. After the fi nal wash, the beads were sus-
pended in 50 μl 2x sample buffer [100 mM Tris/HCl (pH 8.0), 20 % 
glycerol, 4 % SDS] and heated for 5 min at 70 °C. Detection of the 
precipitated protein was performed by using an anti-p300 antibody 
(Santa Cruz Biotechnology). Reciprocal immunoprecipitations were 
performed as described in Results. 
Confocal microscopy. To develop an antibody against bICP0, the 
C terminus of bICP0 was released from pCMV2C-bICP0 by XhoI/SalI 
digestion and cloned into the baculovirus expression vector pBlueBa-
cHis2C (Invitrogen). Recombinant baculovirus was generated by using 
BlueBac DNA and infectious baculovirus was propagated in Spodop-
tera frugiperda 9 insect cells. The bICP0 protein was purifi ed by nickel 
affi nity chromatography and SDS-PAGE and the bICP0 protein was 
eluted from the excised band. The purifi ed bICP0 protein was injected 
into rabbits to generate polyclonal antibodies. Protein G magnetic 
beads were used to purify the IgG. To perform confocal microscopy, 
MDBK cells were split into eight-well Lab-Tek culture slides and incu-
bated for 24 h. Cultured cells were infected with BHV-1 for 4 h. After 
washing with PBS, infected cells were fi xed in 4 % paraformaldehyde 
and then incubated in 100 % ethanol at –20 °C for 2 min. After wash-
ing three times with PBS, slides were blocked with 4 % BSA in PBS 
for 30 min and then incubated with the anti-bICP0 antibody plus the 
anti-p300 antibody (1 : 100 dilution; Upstate) for 2 h at room tempera-
ture. Secondary antibodies Cy2-conjugated donkey anti-rabbit IgG and 
Cy5-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch 
Laboratories) were added to a fi nal concentration of 1 : 100 and incu-
bated for 1 h at room temperature in the dark. After washing with PBS, 
slides were sealed with mounting gel. Images were collected by using a 
Bio-Rad confocal laser-scanning microscope (MRC-1024ES) with ex-
citation/emission at 488/520 nm. 
Analysing the effect of p300 on plaque formation. A BHV-1 
mutant containing the β-galactosidase (β-Gal) gene in place of the vi-
ral gC gene was obtained from S. Chowdury (Manhatten, KS, USA) 
(gCblue virus). This virus grows to titres similar to those of the wild-
type parental virus and expresses the β-Gal gene. The procedures 
for preparing BHV-1 genomic DNA have been described previously 
(Geiser et al., 2002; Inman et al., 2001a, b, 2002). 
β-Gal activity was measured at 24 or 36 h post-transfection as de-
scribed previously (Geiser et al., 2002). The number of β-Gal+ cells in 
cultures transfected with empty expression vector (pcDNA3.1) and vi-
ral genomic DNA was set at a value of 1 for each experiment. Follow-
ing co-transfection of cultures with p300 or bICP0 and the gCblue vi-
rus, the number of β-Gal+ cells was compared with those obtained with 
the empty expression vector and the gCblue virus. This representation 
of the data minimized the differences in cell density, Superfect lot vari-
ation and transfection effi ciency. 
Cloning of the BHV-1 gC promoter. The coding region of the 
gC gene is present in the BHV-1 HindIII-I fragment. The promoter re-
gion and the fi rst in-frame ATG codon of the gC gene were released 
from the HindIII-I fragment by NcoI digestion. The NcoI fragment was 
treated with mung bean nuclease to remove the ATG codon. The blunt-
ended fragment was cloned into the EcoRV site of the Flag-tagged vec-
tor pCMV2C (pCMV2C-gC). pCMV2C-gC was cut with EcoRI and 
digested with Klenow enzyme to create a blunt end. This plasmid was 
then digested with SalI to release the gC promoter region. The reporter 
construct pMinCAT was digested with XbaI and fi lled in with Klenow. 
The TATA box of HSV-1 thymidine kinase was removed by digestion 
with XhoI. The gC promoter fragment (EcoRI–SalI) was ligated into 
the XbaI/XhoI-digested pMinCAT vector (gC-CAT). To generate trun-
cated gC promoter constructs, the upstream gC promoter sequences 
were removed by SalI and XhoI digestion (gC-XhoI-CAT). gC-CAT 
was also digested with PstI to remove a large portion of the promoter 
sequences and the plasmid was religated (gC-PstI-CAT). A schematic 
of these constructs is shown in Figure 6(a). 
Transient transfection and CAT assays. The designated gC pro-
moter constructs and bICP0 expression plasmids were co-transfected 
into FBL or RS cells by using the calcium phosphate precipitation 
method. At 40 h post-transfection, cell lysate was prepared by three 
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freeze–thaw cycles in 0.25 M Tris/HCl (pH 8.0). CAT activity was 
measured in the presence of 0.2 μCi [14C]chloramphenicol and 0.5 mM 
acetyl coenzyme A as described previously (Inman et al., 2001b; Zhang 
& Jones, 2001). The various forms of chloramphenicol were separated 
by thin-layer chromatography and the amount of acetylated chloram-
phenicol was measured with a Bio-Rad Molecular Imager FX. 
RESULTS 
bICP0 interacts with p300 in transiently transfected 
cells
The rationale for testing whether bICP0 interacted with p300 
was that the adenovirus E1A protein and bICP0 appear to 
share certain common functions (Geiser & Jones, 2003) and 
E1A interacts with p300 (Chakravarti et al., 1999; Hamamori 
et al., 1999). To test whether bICP0 interacted with p300, 293 
cells were co-transfected with a Flag-tagged bICP0 expres-
sion construct (Figure 1b) plus a p300 expression plasmid and 
immunoprecipitation/Western blot analysis was performed. 
The bICP0 constructs used in this study, bICP0, ΔbICP0 and 
13G/51A (Figure 1b), expressed similar levels of the Flag-
tagged protein in transiently transfected cells (Figure 1c). 
When bICP0 was immunoprecipitated with the anti-Flag anti-
body, p300 was detected in the immunoprecipitate (Figure 2a). 
The interaction between p300 and bICP0 was also detected by 
immunoprecipitating with p300 and performing Western Blots 
with the anti-Flag antibody to detect bICP0 (Figure 2b). When 
p300 was not overexpressed, low levels of p300 were associ-
ated with bICP0 (data not shown). As these interactions were 
diffi cult to detect on a consistent basis, the results from over-
expression of p300 are presented. An intact C3HC4 zinc RING 
fi nger was apparently not required for the interaction, as the 
13G/51A protein was present in the p300 immunoprecipitate. 
Although the ΔbICP0 protein migrated near to the heavy chain 
of IgG, this truncated protein also interacted with p300. 
Similar levels of p300 were detected at 40 h post-transfection 
when 293 cells were co-transfected with p300 and any one of 
the respective bICP0 constructs (Figure 2c). In agreement with 
a previous study (Saydam et al., 2002), we were unable to de-
tect a stable interaction between bICP0 and p53 in transiently 
transfected cells (Figure 2d). Furthermore, bICP0 expression 
did not reduce steady-state levels of p53 in transiently trans-
fected 293 cells (Figure 2e). Previous studies have also indi-
cated that a stable interaction is not detected between bICP0 
and cyclin-dependent kinase 2 in transiently transfected cells 
(Zhang & Jones, 2001). In summary, the results of these stud-
ies suggested that bICP0 interacted with p300 or a p300-con-
taining complex. 
Figure 2. bICP0 interacts with p300 in transiently transfected cells. 293 cells were transfected with one of the designated 
bICP0 constructs (Figure 1) and p300. At 40 h post-transfection, cell lysate was prepared as described in Methods. (a) 
Cell lysate (1 mg) was incubated with the Flag-specifi c antibody to immunoprecipitate bICP0 and Western blot analy-
sis of theimmunoprecipitate was performed by using p300-specifi c antibody. (b) Protein (1 mg) was immunoprecipitated 
by using anti-p300 antibody (Santa Cruz Biotechnology). The immunoprecipitates were separated by SDS-PAGE (10 % 
gel) and Western blot analysis was performed by using the Flag-specifi c antibody to detect the respective Flag–bICP0 fu-
sion proteins. (c) Overall levels of p300 in transfected cells. For the Western blot, 100 μg protein was added to each lane 
and the proteins were separated by SDS-PAGE (6 % gel). (d) Cell lysate (1 mg) was immunoprecipitated with Flag-spe-
cifi c antibody and Western blot analysis of the immunoprecipitate was performed by using a p53-specifi c antibody (Santa 
Cruz Biotechnology, sc-120). (e) Total levels of p53 in transfected cells. For the Western blot, 100 μg protein was added 
to each lane and theproteins were separated by SDS-PAGE (10 % gel). The position of the IgG heavy chain (HC) is indi-
cated in (b) and (d). Lane V, cell lysate prepared from cells transfected with an empty expression vector (pcDNA3.1).
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bICP0 interacts with p300 in productively infected 
cells
Although our studies suggested that bICP0 interacted with 
p300 in transiently transfected cells, it was important to verify 
that these interactions occur in productively infected cells. To 
test this possibility, RS cells were transfected with 10 μg p300 
expression plasmid for 12 h and then infected with BHV-1 for 
24 h. RS cells were used for this study, as we could transfect 
at least 50 % of the cells and BHV-1 grows to high titres in 
RS cells. Immunoprecipitation was performed initially with a 
polyclonal anti-bICP0 antibody generated against the C termi-
nus of bICP0. For these studies, an IgG fraction was used for 
immunoprecipitation. p300 was consistently detected in the 
immunoprecipitates when anti-bICP0 antiserum was used to 
immunoprecipitate cell lysate prepared from infected RS cells 
(Figure 3a). In contrast, p300 was not detected in immunopre-
cipitates when cell lysate prepared from mock-infected cells 
was immunoprecipitated with anti-bICP0 IgG. Cell lysate pre-
pared from BHV-1-infected RS cells was also immunoprecip-
itated with anti-actin and anti-p300 antibodies. Anti-p300 an-
tibody, but not anti-actin antibody, precipitated bICP0 from 
BHV-1-infected cells (Figure 3b). The interaction between 
p300 and bICP0 was also detected when p300 was not over-
expressed. However, this interaction was easier to detect when 
p300 was overexpressed and, consequently, only these results 
are presented. 
 
bICP0 does not displace p300 from the nucleus af-
ter infection
Confocal microscopy was used to test whether the association 
between bICP0 and p300 altered the subcellular localization 
of p300 after productive infection. MDBK cells were infected 
with BHV-1 for 4 h; cells were fi xed and then immunostained 
with anti-bICP0 and anti-p300 antibodies. bICP0 was detected 
with Cy2-conjugated donkey anti-rabbit antibody (green fl uo-
rescence) and p300 was detected with Cy5-conjugated donkey 
anti-mouse antibody (red fl uorescence). Infected cells express-
ing bICP0 contained p300 and bICP0 in the nucleus (Figure 
4). These results demonstrated that p300 was not displaced 
from the nucleus after infection and confi rmed that p300 lev-
els did not decrease dramatically at 4 h after infection or later 
during infection (data not shown). 
Analysis of the effect of p300 on plaque formation
To test whether p300 overexpression enhanced plaque forma-
tion, bovine cells were co-transfected with BHV-1 genomic 
DNA and increasing concentrations of p300. Transfection of 
bovine cells with BHV-1 genomic DNA yields low levels of 
infectious virus. Co-transfection of BHV-1 DNA with a plas-
mid expressing bICP0 enhances productive infection and vi-
rus yield (Inman et al., 2001b). At 36 h post-transfection, cells 
were fi xed and assayed for β-Gal activity. This time point was 
used as the time to count β-Gal+ cells to minimize the num-
ber of virus-positive cells resulting from virus spread. At later 
times post-transfection, many of the β-Gal+ cells detached from 
the dish, making it diffi cult to count virus-positive cells (Geiser 
& Jones, 2003; Inman et al., 2001b). The number of β-Gal+ 
cells correlates directly with the number of plaques produced 
following transfection with the BHV-1 blue virus (Geiser & 
Jones, 2003; Geiser et al., 2002; Inman et al., 2001b). p300 
consistently increased the level of plaque formation by fourfold 
compared with co-transfection of BHV-1 DNA with the empty 
expression vector (Figure 5). Relative to bICP0, p300 was less 
Figure 3. bICP0 interacts with p300 in productively infected 
cells. RS cells were transfected with 10 μg p300 expression 
plasmid. At 24 h post-transfection, RS cells were infected with-
BHV-1 for 24 h. Whole-cell lysate was then prepared as de-
scribed in Methods. (a) Cell lysate (1 mg) was immunoprecip-
itated with 8 μg anti-bICP0 IgG antibody. Western blots were 
performed with anti-p300 antibody (Santa Cruz Biotechnol-
ogy). (b) Whole-cell lysate (1 mg) from BHV-1-infected RS 
cells was immunoprecipitated with anti-actin or anti-p300 an-
tibody, respectively. The bICP0 protein was detected with anti-
bICP0 IgG. The lanes marked ‘Input’ contained 50 μg whole-
cell lysate per lane.
Figure 4. Nuclear localization of p300 does not change after 
infection. MDBK cells were infected with BHV-1 for 4 h, using 
an m.o.i. of 1. Cells were fi xed and immunostained with rab-
bit anti-bICP0 and mouse anti-p300 (Upstate). bICP0 was de-
tected by using Cy2-conjugated donkey anti-rabbit antibody 
and p300 was detected by using Cy5-conjugated donkey anti-
mouse antibody. Bars, 20 μm.
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effi cient at activating productive infection; to achieve similar 
levels of stimulation, approximately 100-fold more p300 had 
to be included in the transfection mix. 
 
Regulation of gC promoter activity by p300 and 
bICP0
As it is well established that p300 regulates transcription 
(Grunstein, 1997; Tsukiyama & Wu, 1997), we tested whether 
p300 had an effect on a late viral promoter (gC) that is ac-
tivated by bICP0 (Wirth et al., 1992). The gC promoter was 
cloned from the BHV-1 HindIII-I fragment and subcloned up-
stream of a CAT reporter gene lacking a TATA box (gC-CAT; 
Figure 6a). Two additional truncated promoter constructs were 
generated by digestion of promoter sequences with XhoI (gC-
XhoI-CAT) and PstI (gC-PstI-CAT) (Figure 6a). The minimal 
gC promoter tested contained 151 bp of promoter sequences 
upstream of the ATG codon, a consensus TATA box and a 
CAAT box (Hamel & Simard, 2003). Regardless of which gC 
promoter construct was examined, p300 stimulated promoter 
activity by approximately threefold in FBL cells (Figure 6b). 
Deletion of the CH3 domain (ΔCH3) reduced transactivation 
to basal levels, whereas deletion of the CH1 domain (ΔCH1) 
had less of an effect. 
The respective gC promoters were transactivated three- to 
fourfold by bICP0 in FBL cells (Figure 6b). When p300 and 
bICP0 were co-transfected into FBL cells, gC promoter ac-
tivity increased to more than fi vefold over basal levels, which 
was higher than bICP0 or p300 alone (Figure 6b). When the 
ΔCH3 construct was co-transfected with bICP0, the levels of 
transactivation were similar to those seen with bICP0 alone. 
In contrast to the results obtained with the ΔCH3 construct, 
the ΔCH1 construct yielded similar results to the wt p300 con-
struct when co-transfected with bICP0. These results sug-
gested that p300 plus bICP0 cooperate to stimulate gC pro-
moter activity. 
DISCUSSION 
In this study, we demonstrated that bICP0 and p300 inter-
act with each other in transiently transfected 293 cells and in
Figure 5. The p300 gene activates productive infection. Bo-
vine testicular cells (9.1.3) were co-transfected by using Lipo-
fectamine 2000 with increasing amounts of plasmids express-
ing p300 (0.83, 1.66, 3.32 or 6.64 μg) or bICP0 (3.24, 13 or 
51.9 ng) and the BHV-1 blue virus genome (0.83 μg DNA). 
The ratios of bICP0 molecules to viral DNA molecules were 1 
: 4, 1 : 1 and 4 : 1, respectively. The ratios of p300 DNA mol-
ecules to viral genomic DNA molecules were 64 : 1, 128 : 1, 
256 : 1 and 512 : 1, respectively. An empty expression vector 
(pcDNA3.1) was used to maintain equivalent amounts of DNA. 
At 24 h post-transfection, cells were fi xed and stained and the 
number of blue cells was counted. The number of β-Gal+ cells 
in the vector control (pcDNA3.1) was set at a value of 1 and 
the number of β-Gal+ cells in each well was calculated as the 
fold of the vector control. The results are the mean ± SD of 
three independent experiments.
Figure 6. p300 activates the gC promoter. (a) Cloning of the 
gC promoter. The gC gene is located in the HindIII-I fragment. 
The promoter region and the fi rst ATG codon were released by 
NcoI digestion. The ATG was removed by using mung bean 
nuclease and the resulting 1221 bp fragment was cloned up-
stream of the CAT reporter gene from vector pMinCAT, from 
which the TATA box had been removed. Digesting the gC pro-
moterfragment with XhoI or PstI generated two additional trun-
cated promoter constructs. (b) Analysis of gC promoter ac-
tivity. Each of the gC promoter constructs (16 μg) (empty 
bars, gC-CAT; fi lled bars, gC-XhoI-CAT; hatched bars, gC-
PstI-CAT), 2 μg wild-type bICP0 or 2 μg of the p300 expres-
sion vector or a mutant p300 construct was transfected into 
RS cells. To test whether p300 and bICP0 cooperated to ac-
tivatethe gC promoter, 16 μg of one of the gC promoter con-
structs was co-transfected with 2 μg wild-type bICP0 and 2 μg 
p300 expression vector or a mutant p300 construct into RS 
cells. The amount of plasmid DNA for each transfection was 
kept the same by adding empty expression vector. At 40 h 
post-transfection, cell lysate was prepared and CAT activity 
was measured as described in Methods. These results were 
the mean±SD of four independent experiments.
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productively infected bovine cells. In transiently transfected 
293 cells, this interaction did not require an intact bICP0 zinc 
RING fi nger. The fi rst 356 aa of bICP0, which contain the zinc 
RING fi nger, were suffi cient to interact with p300 in 293 cells. 
Although our results suggest that bICP0 interacts with p300, 
they did not allow us to determine whether bICP0 interacts di-
rectly with p300 or with a p300-containing complex. Overex-
pression of p300 was necessary to readily detect of the inter-
action with bICP0 during productive infection or transfection, 
suggesting that other cellular proteins sequester p300 or that 
only a small percentage of bICP0 associates stably with p300. 
As many viral proteins encoded by DNA viruses interact with 
p300 (Vo & Goodman, 2001), we suggest that the ability of 
bICP0 to interact with p300 has functional signifi cance. 
Our results suggest that the interaction between bICP0 and 
p300 enhances productive infection (Figure 5), in part be-
cause p300 activated gC promoter activity (Figure 6). A pre-
vious study concluded that bICP0 did not transactivate the gC 
promoter unless the fragment encompassed nt –1155 to +71 of 
the gC promoter (Hamel & Simard, 2003). In the bovine cells 
that we tested, the minimal gC promoter (gC-PstI-CAT) was 
transactivated by bICP0 with only slightly reduced effi ciency 
compared with the two larger gC promoter constructs. These 
fi ndings are consistent with previous fi ndings that bICP0 is 
capable of activating a simple promoter if it contains a TATA 
box (Inman et al., 2001b; Zhang & Jones, 2001; Zhang et al., 
2005). Additional viral promoters may be activated by p300, 
as the minimal gC promoter tested (gC-PstI-CAT) was acti-
vated by p300. p300 and bICP0 cooperated to transactivate 
the gC promoter more effi ciently than bICP0 or p300 alone. 
The cooperative effect of p300 and bICP0 on gC promoter ac-
tivity may be underestimated, due to endogenous p300 that is 
present in cells. 
p300 activates the innate immune response, in particular tran-
scriptional activation of interferon (IFN)-dependent transcrip-
tion (Munshi et al., 2001; Ogryzko et al., 1996; Sterner & 
Berger, 2000; Vo & Goodman, 2001; Weaver et al., 1998; Yo-
neyama et al., 1998). bICP0 inhibits the IFN-β promoter and 
a simple promoter that contains consensus IFN-stimulated re-
sponse elements in several cell types (Henderson et al., 2005). 
In addition to p300 and bICP0 cooperation to activate gC pro-
moter activity, the interaction between bICP0 and p300 may 
inhibit IFN transcriptional signalling following productive in-
fection. p300 also stimulates other antiviral signalling path-
ways and, as such, is a common target for viral proteins that 
regulate transcription and innate immunity (Vo & Goodman, 
2001). For example, p300 binds to the activation domain of 
p53 and enhances p53-dependent transcription (Gu & Roeder, 
1997; Lill et al., 1997) by acetylating p53 on specifi c resi-
dues (Gu & Roeder, 1997; Gu et al., 1997). We were unable to 
transactivate a simple promoter with bICP0 when consensus 
p53-binding sites were cloned upstream of the TATA box (Y. 
Zhang, unpublished data). Thus, the ability of bICP0 to inter-
act with p300 may prevent p300 from activating antiviral sig-
nalling pathways during the course of productive infection. 
In summary, we suggest that interactions between bICP0 and 
p300 cooperate to enhance viral gene expression and may in-
terfere with antiviral signalling pathways (for example, IFN 
and perhaps the p53 pathway). Our studies also suggest that 
interactions between bICP0 and p300 might alter the HAT ac-
tivity of p300, which could stimulate productive infection indi-
rectly. Several lines of evidence imply that chromatin-remod-
elling enzymes are necessary for effi cient BHV-1 productive 
infection: (i) bICP0 interacts with HDAC1 and inhibits the 
ability of HDAC1 to repress transcription (Zhang & Jones, 
2001); (ii) E2F4 (a cellular protein) stimulates BHV-1 plaque 
formation (Geiser & Jones, 2003) and E2F4 binds HDAC 
family members (Trimarchi & Lees, 2002); (iii) HDAC inhib-
itors accelerate viral gene expression of an HSV-1 ICP0 mu-
tant (Poon et al., 2003); (iv) HSV-1 genomes in productively 
infected cells (Herrera & Triezenberg, 2004; Kent et al., 2004) 
and latently infected neurons (Deshmane & Fraser, 1989) are 
associated with histones; and (v) BHV-1 DNA does not induce 
plaque formation effi ciently unless bICP0 or HSV-1 ICP0 is 
included in the transfection mix (Geiser & Jones, 2003; Inman 
et al., 2001a, b). Future studies will focus on understanding 
whether interactions between bICP0 and chromatin-remodel-
ling enzymes (HDAC1 and p300) infl uence the association of 
histones with the BHV-1 genome. 
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